Have a personal or library account? Click to login
Risk Factors for Tremor in a Population of Patients with Severe Mental Illness: An 18-year Prospective Study in a Geographically Representative Sample (The Curacao Extrapyramidal Syndromes Study XI) Cover

Risk Factors for Tremor in a Population of Patients with Severe Mental Illness: An 18-year Prospective Study in a Geographically Representative Sample (The Curacao Extrapyramidal Syndromes Study XI)

Open Access
|Jun 2017

References

  1. 1
    SmagaSTremorAm Fam Physician2003681545155214596441
  2. 2
    ArbaizarBGómez-AceboILlorcaJPostural induced-tremor in psychiatryPsychiatry Clin Neurosci200862638645doi: http://dx.doi.org/10.1111/j.1440-1819.2008.01877.x19067999
  3. 3
    MorganJCSethiKDDrug-induced tremorsLancet Neurol20054866876doi: http://dx.doi.org/10.1016/S1474-4422(05)70250-716297844
  4. 4
    SirisenaDWilliamsDRMy hands shake: classification and treatment of tremorAust Fam Physician20093867819893794
  5. 5
    PuschmannAWszolekZKDiagnosis and treatment of common forms of tremorSemin Neurol2011316577doi: http://dx.doi.org/10.1055/s-0031-127131221321834
  6. 6
    KandelERSchwartzJHJessellTMPrinciples neural scienceNew YorkMcGraw-Hill2000
  7. 7
    BakkerPRde GrootIWvan OsJvan HartenPNLong-stay psychiatric patients: a prospective study revealing persistent antipsychotic-induced movement disorderPloS ONE20116e25588doi: http://dx.doi.org/10.1371/journal.pone.002558822022416
  8. 8
    MojtabaiROlfsonMNational trends in psychotropic medication polypharmacy in office-based psychiatryArch General Psychiatry2010672636doi: http://dx.doi.org/10.1001/archgenpsychiatry.2009.175
  9. 9
    SukegawaTInagakiAYamanouchiYStudy protocol: safety correction of high dose antipsychotic polypharmacy in JapanBMC Psychiatry201414103doi: http://dx.doi.org/10.1186/1471-244X-14-10324708857
  10. 10
    Van HartenPMatroosGHoekHKahnRThe prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia the Curacao Extrapyramidal Syndromes Study: ISchizophrenia Res199619195203doi: http://dx.doi.org/10.1016/0920-9964(95)00096-8
  11. 11
    TenbackDvan HartenPSlooffCvan OsJEvidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) studyAm J Psychiatry200616314381440doi: http://dx.doi.org/10.1176/ajp.2006.163.8.143816877660
  12. 12
    ShinH-WChungSJDrug-induced parkinsonismJ Clin Neurol201281521doi: http://dx.doi.org/10.3988/jcn.2012.8.1.1522523509
  13. 13
    Van HartenPMatroosGVan OsJThe course of tardive dystonia in Afro Caribbean patients, a population-based study: the Curacao extrapyramidal syndromes study: VIISchizophrenia Res2008987983doi: http://dx.doi.org/10.1016/j.schres.2007.09.010
  14. 14
    Van HartenPNHoekHWMatroosGEvan OsJIncidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curacao extrapyramidal syndromes study VJ Clin Psychiatry20066719201927doi: http://dx.doi.org/10.4088/JCP.v67n121217194270
  15. 15
    FahnSUPDRS Development Committee. Unified Parkinson’s Disease Rating ScaleFlorham Park, NJMacmillan Health Care Information1987
  16. 16
    GuyWECDEU assessment manual for psychopharmacologyRockville, MdU.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs1976https://openlibrary.org/books/OL24341821M/ECDEU_assessment_manual_for_psychopharmacology.
  17. 17
    TRBA rating scale for drug-induced akathisiaBr J Psychiatry1989154672676doi: http://dx.doi.org/10.1192/bjp.154.5.6722574607
  18. 18
    WHO, Collaborating Centre for Drugs Statistics Methodology [Internet][cited 2013 Jun]. Available fromhttp://www.whocc.no/atcddd/2017
  19. 19
    CarnahanRMLundBCPerryPJPollockBGCulpKRThe Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activityJ Clin Pharmacol20064614811486doi: http://dx.doi.org/10.1177/009127000629212617101747
  20. 20
    ZengKWangXXiZYanYAdverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patientsClin Neurol Neurosurg2010112291295doi: http://dx.doi.org/10.1016/j.clineuro.2009.12.01420071075
  21. 21
    Dutch Pharmaceutical reference manual(cited 2013 June). Available fromwww.farmacotherapeutischkompas.nl/
  22. 22
    StataCorp2011Stata Statistical Software: Release 12College Station, TXStataCorp LP
  23. 23
    MenaMAde YébenesJGDrug-induced parkinsonismLondonInforma UK Ltd2006
  24. 24
    ThenganattMAJankovicJParkinson disease subtypesJAMA Neurol201471499doi: http://dx.doi.org/10.1001/jamaneurol.2013.623324514863
  25. 25
    Van HartenPNHoekHWMatroosGEKoeterMKahnRSThe inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curacao Extrapyramidal Syndromes Study IISchizophrenia Res199726235242doi: http://dx.doi.org/10.1016/S0920-9964(97)00058-3
  26. 26
    HillABThe environment and disease: association or causation?Proc R Soc Med19655829514283879
  27. 27
    CaroffSNHurfordILybrandJCampbellECMovement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trialNeurologic Clinics201129127148doi: http://dx.doi.org/10.1016/j.ncl.2010.10.00221172575
  28. 28
    DayaluPChouKLAntipsychotic-induced extrapyramidal symptoms and their managementLondonInforma UK Ltd2008doi: http://dx.doi.org/10.1517/14656566.9.9.1451
DOI: https://doi.org/10.5334/tohm.336 | Journal eISSN: 2160-8288
Language: English
Submitted on: Apr 11, 2017
Accepted on: May 26, 2017
Published on: Jun 27, 2017
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2017 Charlotte L. Mentzel, P. Roberto Bakker, Jim van Os, Marjan Drukker, Michiel R. H. van den Oever, Glenn E. Matroos, Hans W. Hoek, Marina AJ Tijssen, Peter N. van Harten, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.